4.20MMarket Cap-245P/E (TTM)
1.3695High1.2800Low21.33KVolume1.3695Open1.3300Pre Close27.87KTurnover0.74%Turnover RatioLossP/E (Static)3.26MShares18.000052wk High0.70P/B3.72MFloat Cap1.280052wk Low--Dividend TTM2.89MShs Float284.7980Historical High--Div YieldTTM6.73%Amplitude1.2800Historical Low1.3060Avg Price1Lot Size
Processa Pharmaceuticals Stock Forum
Processa Pharmaceuticals : Ngc-Cap Phase 1B T - moomoo
Processa Pharmaceuticals Inc: Studies Support Potential Benefit as an Improved Treatment With Fewer Side Effects
https://www.moomoo.com/t/news/flash/19012294/fyryNQAmzb
Processa Pharmaceuticals, Inc. (Nasdaq: PCSA), a clinical-stage pharmaceutical company dedicated to developing next-generation chemotherapeutic drugs with enhanced efficacy and safety, has announced a major development. The U.S. Food and Drug Administration (FDA) has cleared the company's Invest...
No comment yet